Tim Schmidt
Directeur/Membre du Conseil chez Chrysalis BioTherapeutics, Inc.
Profil
Timothy Schmidt currently works as a Director at Chrysalis BioTherapeutics, Inc.
Postes actifs de Tim Schmidt
| Sociétés | Poste | Début |
|---|---|---|
Chrysalis BioTherapeutics, Inc.
 Chrysalis BioTherapeutics, Inc. Pharmaceuticals: OtherHealth Technology Part of Capstone Therapeutics Corp., Chrysalis BioTherapeutics, Inc. develops therapeutics to accelerate the healing of hard and soft tissue. The company is based in Galveston, TX. The company was founded by Dennis L. McWilliams. Chrysalis BioTherapeutics was acquired by Capstone Therapeutics Corp. on August 06, 2004 for $34.50 million. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Chrysalis BioTherapeutics, Inc.
Chrysalis BioTherapeutics, Inc. Pharmaceuticals: OtherHealth Technology Part of Capstone Therapeutics Corp., Chrysalis BioTherapeutics, Inc. develops therapeutics to accelerate the healing of hard and soft tissue. The company is based in Galveston, TX. The company was founded by Dennis L. McWilliams. Chrysalis BioTherapeutics was acquired by Capstone Therapeutics Corp. on August 06, 2004 for $34.50 million. | Health Technology |
